Emanuel Stutz Selected Research

Radiotherapy

2/2022	Present Practice of Radiative Deep Hyperthermia in Combination with Radiotherapy in Switzerland.
8/2021	Radiation-Associated Angiosarcoma of the Breast and Chest Wall Treated with Thermography-Controlled, Contactless wIRA-Hyperthermia and Hypofractionated Re-Irradiation.
1/2021	Quantification of thermal dose in moderate clinical hyperthermia with radiotherapy: a relook using temperature-time area under the curve (AUC).
5/2020	Is it safe to irradiate the newest generation of ventricular assist devices? A case report and systematic literature review.
1/2019	A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy.
1/2019	Efficacy and Safety Evaluation of the Various Therapeutic Options in Locally Advanced Cervix Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
7/2018	Clinical estimation of α/β values for prostate cancer from isoeffective phase III randomized trials with moderately hypofractionated radiotherapy.
11/2017	Conventional Versus Hypofractionated Radiation Therapy for Localized or Locally Advanced Prostate Cancer: A Systematic Review and Meta-analysis along with Therapeutic Implications.
1/2017	Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuel Stutz Research Topics

Disease

6	Hyperthermia 02/2022 - 01/2019
3	Neoplasms (Cancer) 08/2021 - 02/2014
2	Angiosarcoma of the breast 11/2021 - 08/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 11/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020
1	Lung Neoplasms (Lung Cancer) 02/2014

Drug/Important Bio-Agent (IBA)

1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	saracatinibIBA 02/2014
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 02/2014
1	CrizotinibIBA 02/2014

Therapy/Procedure

9	Radiotherapy 02/2022 - 01/2017
2	Chemoradiotherapy 01/2019 - 01/2017
1	Combined Modality Therapy 11/2021
1	Neoadjuvant Therapy 10/2021
1	Re-Irradiation 08/2021
1	Induced Hyperthermia (Thermotherapy) 01/2019
1	Drug Therapy (Chemotherapy) 01/2019